PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.79%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
987.72%
Positive gross profit growth while ECL.AX is negative. John Neff would see a clear operational edge over the competitor.
165.89%
Positive EBIT growth while ECL.AX is negative. John Neff might see a substantial edge in operational management.
165.89%
Positive operating income growth while ECL.AX is negative. John Neff might view this as a competitive edge in operations.
479.74%
Positive net income growth while ECL.AX is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.46%
Reduced diluted shares while ECL.AX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-163.38%
Negative OCF growth while ECL.AX is at 342.95%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-201.42%
Negative FCF growth while ECL.AX is at 362.05%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
10.79%
Positive 10Y revenue/share CAGR while ECL.AX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
119.97%
Positive 5Y CAGR while ECL.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-28.44%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-1016.95%
Negative 10Y OCF/share CAGR while ECL.AX stands at 179.15%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-462.70%
Negative 5Y OCF/share CAGR while ECL.AX is at 270.02%. Joel Greenblatt would question the firm’s operational model or cost structure.
-47.31%
Negative 3Y OCF/share CAGR while ECL.AX stands at 18.61%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
336.32%
Positive 10Y CAGR while ECL.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
1037.50%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
-62.50%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
99.31%
5Y equity/share CAGR above 1.5x ECL.AX's 42.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
55.73%
3Y equity/share CAGR above 1.5x ECL.AX's 30.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.72%
Our AR growth while ECL.AX is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
30.13%
We show growth while ECL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.81%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
8.82%
1.25-1.5x ECL.AX's 6.73%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-10.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
133.02%
We expand SG&A while ECL.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.